1. Home
  2. DYN vs GOGL Comparison

DYN vs GOGL Comparison

Compare DYN & GOGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DYN
  • GOGL
  • Stock Information
  • Founded
  • DYN 1984
  • GOGL N/A
  • Country
  • DYN United States
  • GOGL Bermuda
  • Employees
  • DYN N/A
  • GOGL N/A
  • Industry
  • DYN Medicinal Chemicals and Botanical Products
  • GOGL Marine Transportation
  • Sector
  • DYN Health Care
  • GOGL Consumer Discretionary
  • Exchange
  • DYN Nasdaq
  • GOGL Nasdaq
  • Market Cap
  • DYN 2.6B
  • GOGL 2.6B
  • IPO Year
  • DYN 2020
  • GOGL 1997
  • Fundamental
  • Price
  • DYN $25.95
  • GOGL $8.97
  • Analyst Decision
  • DYN Strong Buy
  • GOGL Hold
  • Analyst Count
  • DYN 11
  • GOGL 3
  • Target Price
  • DYN $51.18
  • GOGL $12.25
  • AVG Volume (30 Days)
  • DYN 836.3K
  • GOGL 1.9M
  • Earning Date
  • DYN 11-12-2024
  • GOGL 11-27-2024
  • Dividend Yield
  • DYN N/A
  • GOGL 13.61%
  • EPS Growth
  • DYN N/A
  • GOGL 102.13
  • EPS
  • DYN N/A
  • GOGL 1.22
  • Revenue
  • DYN N/A
  • GOGL $1,011,652,000.00
  • Revenue This Year
  • DYN N/A
  • GOGL N/A
  • Revenue Next Year
  • DYN N/A
  • GOGL $0.90
  • P/E Ratio
  • DYN N/A
  • GOGL $7.37
  • Revenue Growth
  • DYN N/A
  • GOGL 14.81
  • 52 Week Low
  • DYN $11.66
  • GOGL $8.73
  • 52 Week High
  • DYN $47.45
  • GOGL $15.77
  • Technical
  • Relative Strength Index (RSI)
  • DYN 38.55
  • GOGL 23.25
  • Support Level
  • DYN $25.27
  • GOGL $8.73
  • Resistance Level
  • DYN $28.96
  • GOGL $9.99
  • Average True Range (ATR)
  • DYN 1.41
  • GOGL 0.20
  • MACD
  • DYN -0.23
  • GOGL -0.07
  • Stochastic Oscillator
  • DYN 14.25
  • GOGL 15.47

About DYN Dyne Therapeutics Inc.

Dyne Therapeutics Inc is a biotechnology company focused on providing therapeutics for patients with genetically driven diseases. The company overcomes the limitations of muscle tissue delivery and modern oligonucleotide therapeutics for muscle diseases. The company is developing therapies for muscle disorders like Myotonic dystrophy, Duchenne muscular dystrophy, and Facioscapulohumeral muscular dystrophy. The company's product candidates are DYNE-101 and DYNE-251, both are in the ongoing phase 1/2 clinical trial.

About GOGL Golden Ocean Group Limited

Golden Ocean Group Ltd is a Bermuda-based dry bulk shipping company. Its business involves the transportation of dry bulk cargo including ores, coal, grains and fertilizers through its fleet of owned and chartered vessels, bareboat vessels, commercial management vessels and new buildings are chartered-out on fixed rate time charters and index-linked time charter contracts.

Share on Social Networks: